• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Valley Health System Becomes First in New Jersey to Prescribe Enterprise-wide Digital Therapeutics in Partnership with Rx.Health

Share:

January 14, 2020

As Rx.Health continues to partner with leading health systems across the United States, the company has announced that it will be implementing its flagship Digital Therapeutics Prescribing Platform and EHR-integrated RxStitch Engine to support episodes of care and enterprise-wide digital transformation at Valley Health System. This partnership marks Rx.Health’s entry into the New Jersey healthcare market.

“Partnering with Valley Health System confirms that sophisticated health systems are ready to engage Digital Medicine and Digital Therapeutics to offer patients the best care plans,” said Rx.Health VP Strategic Partnerships Gaurav Narang. “Currently, digital health is quite fragmented and unaffordable. Our mission statement has always been to support enterprise-wide digital transformation and address fragmentation in digital health by supporting multiple-use-cases under one umbrella, so implementing at Valley Health is in direct alignment with that goal.”

Valley Health System will be utilizing Rx.Health to prescribe digital therapeutics and navigation for multiple initiatives and service-lines, including Medicare episodes of care and perioperative support, as well as for the closure of care gaps in at-risk populations. The digital navigation program will utilize the RxStitch engine, which Rx.Health released earlier this year in partnership with the American Gastroenterological Association and the American College of Cardiology.

“Utilizing technology to increase engagement and collaboration with our patient population is in our DNA,” said Dr. Robert Brenner, President, Clinical Integration & Physician Enterprise at Valley Health System. “Partnering with Rx.Health is a natural extension of our commitment to provide continuous and comprehensive care universally to all patients through innovation.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“It is incredible to see that within 45 days, we have gone from signing the contract to making digital navigation available to our patients undergoing complex electrophysiological studies and procedures,” said Dr. Suneet Mittal, Director of the Snyder Center for Comprehensive Atrial Fibrillation. “In 2020, we plan to expand the current program to support telemedicine and devices for remote patient monitoring across the entire spectrum of cardiovascular care.”

Source: USA TODAY Classifieds

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Agilis Biotherapeutics Sells to PTC for $200 MillionAgilis Biotherapeutics Sells to PTC for $200 Million
  • Sobi™ Completes Acquisition of the Global Rights for Emapalumab From NovimmuneSobi™ Completes Acquisition of the Global Rights for Emapalumab From Novimmune
  • Arcturus Therapeutics Acquires Exclusive License to mRNA Manufacturing Technology from Alexion PharmaceuticalsArcturus Therapeutics Acquires Exclusive License to mRNA Manufacturing Technology from Alexion Pharmaceuticals
  • SCI Solutions Acquires Mobile Patient Data Collection & Payments Platform Tonic HealthSCI Solutions Acquires Mobile Patient Data Collection & Payments Platform Tonic Health
  • 8 Startups Ahead of the Pulse in Healthcare8 Startups Ahead of the Pulse in Healthcare
  • Eliminating the Long, Cumbersome and Costly Diagnosis of Genetic DiseasesEliminating the Long, Cumbersome and Costly Diagnosis of Genetic Diseases
  • Progenics Activist Calls Buyout Deal ‘Value-Destructive’Progenics Activist Calls Buyout Deal ‘Value-Destructive’
  • Acticor Biotech Raises €7M In Addition to Its Series B Financing, Now Completed At €22,3MActicor Biotech Raises €7M In Addition to Its Series B Financing, Now Completed At €22,3M

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications